Argyria attributed to silvadene application in a patient with dystrophic epidermolysis bullosa

John C. Browning; Moise L. Levy

Argyria attributed to silvadene application in a patient with dystrophic epidermolysis bullosa

Research output: Contribution to journal › Article › peer-review

Abstract

Argyria is most commonly reported in association with prolonged ingestion of silver-containing medicaments. This case illustrates the rather unique case of development of argyria following application of silver sulfadiazine in a patient with epidermolysis bullosa.

Original language	English (US)
Article number	9
Journal	Dermatology online journal
Volume	14
Issue number	4
State	Published - Apr 1 2008
Externally published	Yes

ASJC Scopus subject areas

Dermatology

Cite this

@article{95a83be9c4aa4a40b5114a45eae179a4,

title = "Argyria attributed to silvadene application in a patient with dystrophic epidermolysis bullosa",

abstract = "Argyria is most commonly reported in association with prolonged ingestion of silver-containing medicaments. This case illustrates the rather unique case of development of argyria following application of silver sulfadiazine in a patient with epidermolysis bullosa.",

author = "Browning, {John C.} and Levy, {Moise L.}",

year = "2008",

month = apr,

day = "1",

language = "English (US)",

volume = "14",

journal = "Dermatology Online Journal",

issn = "1087-2108",

publisher = "Department of Dermatology UC Davis",

number = "4",

}

TY - JOUR

T1 - Argyria attributed to silvadene application in a patient with dystrophic epidermolysis bullosa

AU - Browning, John C.

AU - Levy, Moise L.

PY - 2008/4/1

Y1 - 2008/4/1

N2 - Argyria is most commonly reported in association with prolonged ingestion of silver-containing medicaments. This case illustrates the rather unique case of development of argyria following application of silver sulfadiazine in a patient with epidermolysis bullosa.

AB - Argyria is most commonly reported in association with prolonged ingestion of silver-containing medicaments. This case illustrates the rather unique case of development of argyria following application of silver sulfadiazine in a patient with epidermolysis bullosa.

UR - http://www.scopus.com/inward/record.url?scp=43449133864&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43449133864&partnerID=8YFLogxK

M3 - Article

C2 - 18627731

AN - SCOPUS:43449133864

VL - 14

JO - Dermatology Online Journal

JF - Dermatology Online Journal

SN - 1087-2108

IS - 4

M1 - 9

ER -

Argyria attributed to silvadene application in a patient with dystrophic epidermolysis bullosa

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this